Article info
PDFEditorial commentary
Risk prediction and treatment monitoring are crucial for prevention and management of compulsive dopamine use in Parkinson's disease
- Correspondence to Dr O A van den Heuvel, Department of Psychiatry, VU University Medical Center, PO Box 7057, Amsterdam 1007 MB, The Netherlands; oa.vandenheuvel{at}vumc.nl
Citation
Risk prediction and treatment monitoring are crucial for prevention and management of compulsive dopamine use in Parkinson's disease
Publication history
- Received March 29, 2013
- Accepted April 14, 2013
- First published May 14, 2013.
Online issue publication
April 13, 2016
Article Versions
- Previous version (13 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions